Suzhou Hanzu Medical Technology Co., Ltd. is a professional technology-driven enterprise integrating R&D, production, and sales of oral implantological devices. With nearly two decades of proven experience in the synergistic development of medical, engineering, and research disciplines in both surgical and orthopedic fields, the company holds multiple invention patents.

The Hanzu Implant System is developed by Hanzu in collaboration with international and domestic implant design experts, clinical implant specialists, and manufacturing process engineers. It incorporates advanced international design concepts while being tailored to the bone quality and physiological characteristics of the Asian population. In 2023, the Hanzu CHAMPION Implant System was included in the first batch of Category A products under the national centralized procurement program. In 2026, the Hanzu PURA Implant System was officially launched, and the premium hydrophilic implant has also commenced the regulatory submission process with the National Medical Products Administration.

With years of deep commitment to the oral implant field, Hanzu has established an integrated value chain covering material research, precision manufacturing, and clinical support. Committed to independent innovation, the company actively collaborates with multiple universities and research institutes to advance industry-academia-research integration, achieving significant technological breakthroughs in implant materials, surface treatments, and structural design.